Italy Eyelashes Enhancing Agents Market, By Content,
Italy Eyelashes Enhancing Agents Market, By Content,
By Content, the market is segmented into Bimatoprost, Lash-building serum, Skincare Ingredients, Herbal Remedy, Isopropyl Cloprostenate, Enhancer Serum, and Others (2017-2027)
| Label | Bimatoprost | Lash-building serum | Skincare Ingredients | Herbal Remedy | Isopropyl Cloprostenate | Enhancer Serum | Others | Total |
|---|---|---|---|---|---|---|---|---|
| 2017 | 2.28 USD Mn | 0.43 USD Mn | 0.61 USD Mn | 1.24 USD Mn | 0.44 USD Mn | 1.96 USD Mn | 1.36 USD Mn | 8.32 USD Mn |
| 2018 | 2.43 USD Mn | 0.46 USD Mn | 0.65 USD Mn | 1.32 USD Mn | 0.46 USD Mn | 2.07 USD Mn | 1.42 USD Mn | 8.83 USD Mn |
| 2019 | 2.59 USD Mn | 0.5 USD Mn | 0.7 USD Mn | 1.41 USD Mn | 0.49 USD Mn | 2.19 USD Mn | 1.49 USD Mn | 9.36 USD Mn |
| 2020 | 2.76 USD Mn | 0.53 USD Mn | 0.74 USD Mn | 1.5 USD Mn | 0.51 USD Mn | 2.31 USD Mn | 1.56 USD Mn | 9.91 USD Mn |
| 2021 | 2.88 USD Mn | 0.56 USD Mn | 0.77 USD Mn | 1.56 USD Mn | 0.53 USD Mn | 2.4 USD Mn | 1.6 USD Mn | 10.3 USD Mn |
| 2022 | 3.01 USD Mn | 0.59 USD Mn | 0.8 USD Mn | 1.63 USD Mn | 0.55 USD Mn | 2.49 USD Mn | 1.64 USD Mn | 10.7 USD Mn |
| 2023 | 3.15 USD Mn | 0.62 USD Mn | 0.84 USD Mn | 1.7 USD Mn | 0.56 USD Mn | 2.58 USD Mn | 1.68 USD Mn | 11.13 USD Mn |
| 2024 | 3.3 USD Mn | 0.65 USD Mn | 0.87 USD Mn | 1.78 USD Mn | 0.58 USD Mn | 2.68 USD Mn | 1.73 USD Mn | 11.6 USD Mn |
| 2025 | 3.47 USD Mn | 0.69 USD Mn | 0.91 USD Mn | 1.86 USD Mn | 0.61 USD Mn | 2.79 USD Mn | 1.78 USD Mn | 12.1 USD Mn |
| 2026 | 3.65 USD Mn | 0.73 USD Mn | 0.96 USD Mn | 1.95 USD Mn | 0.63 USD Mn | 2.91 USD Mn | 1.84 USD Mn | 12.66 USD Mn |
| 2027 | 3.84 USD Mn | 0.77 USD Mn | 1.01 USD Mn | 2.05 USD Mn | 0.65 USD Mn | 3.04 USD Mn | 1.9 USD Mn | 13.26 USD Mn |
Data Source: Wantstats Repository
Growth Outlook
- The Italy Eyelashes Enhancing Agents Market, By Content, market is on a steady long-term growth path. Segment value stands at roughly USD 13 Mn in 2026 and is projected to reach USD 13 Mn by 2027 — a gain of about 5% over the forecast period, translating to a CAGR in the mid-single digits.
- By 2027, Bimatoprost is the largest of the 7 groups tracked here, at 3. 84M USD, 29% of the combined total.
- What the regional split looks like (2026): Bimatoprost leads, holding roughly 29% of segment value — the single largest regional share. Enhancer Serum is the second-largest contributor. Herbal Remedy, Others, Skincare Ingredients, Lash-building serum and Isopropyl Cloprostenate make up the remainder, in descending order.
- By 2027, Bimatoprost alone is expected to reach USD 4 Mn, with Enhancer Serum at USD 3 Mn.
Market Dynamics
By 2027, Bimatoprost is the largest of the 7 groups tracked here, at 3.84M USD, 29% of the combined total.
Enhancer Serum is runner-up at 3.04M USD — 21% off the lead.
Bimatoprost grows to 3.84M USD by 2027, from 2.28M USD in 2017 — 68% up.
Enhancer Serum climbs from 1.96M USD (2017) to 3.04M USD (2027), a 55% gain.
Herbal Remedy: 1.24M USD to 2.05M USD, 65% higher by 2027.
Others: up 40% over the period, 1.36M USD to 1.90M USD.
Skincare Ingredients: 610.00K USD in 2017 to 1.01M USD by 2027, up 66%.
Lash-building serum grows to 770.00K USD by 2027, from 430.00K USD in 2017 — 79% up.
The fastest mover is Lash-building serum, up 79% over the period — a steeper climb than any of the other 7 groups here.
The 7-group total: 8.32M USD in 2017, 13.26M USD by 2027, 59% overall.
How To Compare These 7 Groups
There are 7 separate series stacked into this one chart. Look at relative size and relative movement, not just whichever line sits highest.
Do not confuse "biggest" with "fastest-growing" — they are frequently different series on a chart like this one, and the gap between them can close faster than the current ranking suggests.
For planning purposes, the end-year figure and the growth rate are the two numbers that matter. Together they show how large the Italy Eyelashes Enhancing Agents market is projected to become and how quickly it gets there.
The numbers here come from a market sizing model: historical revenue estimates up to the 2018 base year, then forecasts through 2027 using growth-rate assumptions for each segment. The underlying report explains the methodology in detail.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



